Cirsium Biosciences
Chemicals & Related Products · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8500 Redwood Creek Ln Ste A, San Diego, ...Website
www.cirsiumbio.comRevenue
<$5 MillionIndustry
About Cirsium Biosciences
Cirsium Biosciences is focused on democratizing gene therapy through innovative viral vector production methods that utilize whole plants as bioreactors. Their platform addresses manufacturing bottlenecks by providing highly scalable, rapid, and cost-effective solutions for producing recombinant AAV vectors. By significantly reducing lead times and simplifying the supply chain, they aim to enhance access to vital gene therapies for patients. The company targets clients in the biotechnology and pharmaceutical sectors seeking efficient and standardized clinical-grade production methods.Explore more
Cirsium Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Cirsium Biosciences
Compare insights from companies similar to Cirsium Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cirsium Biosciences Tech Stack
A closer look at the technologies used by Cirsium Biosciences
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cirsium Biosciences
Sign Up For FreeTo access detailed company insights
Cirsium Biosciences is focused on democratizing gene therapy through innovative viral vector production methods that utilize whole plants as bioreactors. Their platform addresses manufacturing bottlenecks by providing highly scalable, rapid, and cost-effective solutions for producing recombinant AAV vectors. By significantly reducing lead times and... Read More
